Medline Inc.
MDLNNasdaq
$39.79
↓ -3.2%Jul 17 close · end-of-day
Price
1Y↓ -3.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$32.2B
Enterprise Value
$42.6B
P/E
—
P/S
1.1
P/B
2.9
EV/EBITDA
13.2
PEG
—
FCF Yield
4.0%
Dividend Yield
—
Revenue (TTM)
$28.4B
Net Income (TTM)
$1.2T
Free Cash Flow (TTM)
$1.3B
Gross Margin
26.4%
Operating Margin
7.8%
Net Margin
4069.4%
ROE
10264.4%
ROIC
9.5%
Debt / Equity
1.1
Net Cash
-$10.3B
Return 1Y
—
Company profile
Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Our principal executive offices are located in Northfield, Illinois.
- CEO
- James M. Boyle
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 43,000
- Headquarters
- Illinois
- Website
- www.medline.com
Management & directors
- Golwas Douglas PChief Commercial Officer
- Abrams William JSee Remarks
- Boyle James MChief Executive Officer
- Drazin Michael BChief Financial Officer
- Laabs Amanda H.Chief Product Officer
- Liberman Alexander M.Chief Legal Officer
- Miller Stephen LChief Operating Officer
- Shryock Christopher PChief Human Resources Officer
- Corcoran Jessi LPrincipal Accounting Officer
Roles derived from SEC Form 4 filings.
Earnings
MDLN Q1 2026 Earnings
Period ends 2026-03-28
MetricActualYoY
Revenue$7.4B↑ +10.7%
Diluted EPS$0.16—
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $23.2B | $25.5B | $28.4B |
| Gross profit | $5.9B | $7.0B | $7.5B |
| Operating income | $1.3B | $2.1B | $2.2B |
| Net income | — | — | $1.2T |
| Diluted EPS | — | — | -$0.01 |
| Operating cash flow | $1.7B | $1.8B | $1.7B |
| Free cash flow | $1.4B | $1.4B | $1.3B |
| Gross margin | 25.3% | 27.3% | 26.4% |
| Operating margin | 5.4% | 8.4% | 7.8% |
| Net margin | — | — | 4069.4% |
| Line item | Q1 '25 | Q1 '26 |
|---|---|---|
| Revenue | $6.6B | $7.4B |
| Gross profit | $1.8B | $1.8B |
| Operating income | $571.0M | $422.0M |
| Net income | $319.0M | — |
| Diluted EPS | — | $0.16 |
| Operating cash flow | $682.0M | $412.0M |
| Free cash flow | $584.0M | $316.0M |
| Gross margin | 27.5% | 25.0% |
| Operating margin | 8.6% | 5.7% |
| Net margin | 4.8% | — |
Company news
Jul 12, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-16 | Golwas Douglas P· Chief Commercial Officer | Sale | 61,966 | $36.60 | $2.3M | filing |
| 2026-06-16 | Golwas Douglas P· Chief Commercial Officer | Sale | 38,034 | $37.05 | $1.4M | filing |
| 2026-06-16 | Golwas Douglas P· Chief Commercial Officer | Option exercise | 100,000 | — | — | filing |
| 2026-06-16 | Golwas Douglas P· Chief Commercial Officer | D | 100,000 | — | — | filing |
| 2026-06-15 | Boyle James M· Chief Executive Officer | Tax withholding | 2,370 | $36.61 | $86,765.70 | filing |
| 2026-06-15 | Laabs Amanda H.· Chief Product Officer | Tax withholding | 1,889 | $36.61 | $69,156.29 | filing |
| 2026-06-15 | Miller Stephen L· Chief Operating Officer | Tax withholding | 1,889 | $36.61 | $69,156.29 | filing |
| 2026-06-15 | Drazin Michael B· Chief Financial Officer | Tax withholding | 1,889 | $36.61 | $69,156.29 | filing |
| 2026-06-15 | Golwas Douglas P· Chief Commercial Officer | Tax withholding | 1,889 | $36.61 | $69,156.29 | filing |
| 2026-06-15 | Abrams William J· See Remarks | Tax withholding | 1,308 | $36.61 | $47,885.88 | filing |
| 2026-06-15 | Shryock Christopher P· Chief Human Resources Officer | Tax withholding | 872 | $36.61 | $31,923.92 | filing |
| 2026-06-15 | Liberman Alexander M.· Chief Legal Officer | Tax withholding | 872 | $36.61 | $31,923.92 | filing |
| 2026-06-11 | GALANTI RICHARD A | Award | 5,387 | $0.00 | $0.00 | filing |
| 2026-06-11 | Bluedorn Todd M | Award | 5,387 | $0.00 | $0.00 | filing |
| 2026-06-11 | Sweet Thomas W | Award | 5,387 | $0.00 | $0.00 | filing |
| 2026-06-05 | CORCORAN JESSI L· Principal Accounting Officer | Buy | 5,000 | $34.15 | $170,750.00 | filing |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sale | 19,712,326 | $36.54 | $720.2M | filing |
| 2026-05-28 | BX Mozart ML-2 Holdco L.P. | Sale | 19,712,326 | $36.54 | $720.2M | filing |
| 2026-05-28 | Hellman & Friedman Capital Partners X (Parallel), L.P. | Sale | 17,947,337 | $36.54 | $655.8M | filing |
| 2026-05-28 | Hellman & Friedman Capital Partners X (Parallel), L.P. | Sale | 11,904,646 | $36.54 | $435.0M | filing |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sale | 9,858,774 | $36.54 | $360.2M | filing |
| 2026-05-28 | BX Mozart ML-2 Holdco L.P. | Sale | 9,858,774 | $36.54 | $360.2M | filing |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sale | 2,256,800 | $36.54 | $82.5M | filing |
| 2026-05-28 | BX Mozart ML-2 Holdco L.P. | Sale | 2,256,800 | $36.54 | $82.5M | filing |
| 2026-05-28 | BX Mozart ML-2 Holdco L.P. | Sale | 1,489,924 | $36.54 | $54.4M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.